期刊名称：JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
The Journal of Acquired Immune Deficiency Syndromes (JAIDS) is an interdisciplinary journal co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology. It provides a synthesis of information on AIDS and human retrovirology from all relevant clinical and basic sciences. Under the guidance of an eminent international editorial board, this groundbreaking journal brings together rigorously peer-reviewed original articles, reviews of current research, results of clinical trials, well-documented case reports, and discussions of national policy issues.
Instructions to Authors
Manuscript Submission
A submitted manuscript must be an original contribution not previously published (except as an abstract or preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the journal, its editors, or the publisher.
All submissions will be rigorously peer-reviewed by members of the Editorial Board, and possibly by other specially qualified individuals as well. In the interests of rapid reviewing of contributions, only one of the Editors-in-Chief will, in general, make the final determination as to the acceptability of a submission, after collecting the referee's comments. Contributors may recommend specific names of reviewers from the Editorial Board, as well as other individuals they deem especially well qualified. However, the Editors-in-Chief will not be bound to follow such suggestions.
In general, the instructions for preparation of manuscripts are essentially the same as those for such journals as Science and Nature. In case of questions, please feel free to call the Editorial Office of any one of the Editors-in-Chief.
Authors must submit their manuscripts through the Web-based tracking system: Basic Science (http://jaids-basicscience.edmgr.com), Clinical Science (http://jaids-clinical.edmgr.com), or Epidemiology (http://jaids-epidemiology.edmgr.com). The site contains instructions and advice on how to use the system, guidance on the creation/scanning and saving of electronic art, and supporting documentation. In addition to allowing authors to submit manuscripts on the Web, the site allows authors to follow the progression of their manuscript through the peer review process. Authors who do submit their manuscripts through the Web-based tracking system are asked not to send hard copies of the manuscript to the editorial office. They may, however, send to the editorial office any artwork, letters, or files that cannot be submitted electronically. Address all inquiries regarding manuscripts not yet accepted or published to the Journal's editorial office. The editorial office will acknowledge receipt of your manuscript via email.
Editorial Office Addresses:
Basic Science Articles:
David D. Ho, MD
The Aaron Diamond AIDS Research Center
455 First Avenue
New York, NY 10016
(212) 448-5171
Fax: (212) 725-1126
Clinical Articles:
Paul A. Volberding, MD
San Francisco VA Medical Center
Building 16
4150 Clement Street
VAMC 111V
San Francisco, CA 94121
(415) 379-5546
Fax: (415) 379-5547
Epidemiology Articles:
William A. Blattner, MD
725 West Lombard Street
Room 449
Baltimore, MD 21201
(410) 706-1941
Fax: (410) 706-1944
Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask patients' eyes and remove patients' names from figures unless they obtain written consent from the patients and submit written consent with the manuscript
Copyright: All authors must sign a copy of the journal's "Authorship Responsibility, Financial Disclosure, and Copyright Transfer" form and submit it via fax or mail after submitting the original manuscript online.
Permissions: Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source. Any permissions fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material, not the responsibility of Lippincott Williams & Wilkins.
Preparation of Manuscript
Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
General format: Manuscripts must be in English. Double-space all copy, including legends, footnotes, tables, and references.
Online submission: Manuscript files must be uploaded into the Editorial Manager online interface. Most file formats are acceptable. Editorial Manager will then create PDF files of the authors' submission, and the author must view and approve the files before they will be submitted to the editorial office. Please be sure that the "manuscript" file contains complete text for your submission (title page and abstract), as this is the file that will be downloaded by the reviewers and publisher. Please note, figures and tables may be submitted as separate files.
Please note that once the paper has been accepted for publication, and final versions of the manuscript, figures, and table files have been uploaded to the Editorial Manager interface, PDF files will not be used for typesetting. This is important to note for Table and Figure files, which may lose formatting when converted to PDF, but will remain intact in their original format.
Title page: A title page must be included in the manuscript file. Include on the title page (a) complete manuscript title; (b) authors' full names and affiliations; (c) name and address for correspondence, including fax number, telephone number, and e-mail address; (d) address for reprints if different from that of corresponding author; and (e) sources of support that require acknowledgment.
Abstract and key words: Limit the abstract to 200 words. It must be factual and comprehensive. Limit the use of abbreviations and acronyms, and avoid general statements (eg, "the significance of the results is discussed"). List three to six key words or phrases.
Text: Organize the manuscript file into sections with appropriate section headings. The sequence should be as follows: title page, abstract/key word page, introduction, methods, results, discussions, acknowledgments, references, tables, figure captions.
Authors should type, whenever possible, all mathematical and chemical symbols, equations, and formulas, and identify all unusual symbols the first time they are used. Define abbreviations at first mention in text and in each table and figure. If a brand name is cited, supply the manufacturer's name and address (city and state/country). Acknowledge all forms of support, including pharmaceutical and industry support, in an Acknowledgments paragraph.
Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. Write out the full term for each abbreviation at its first use unless it is a standard unit of measure.
References: The authors are responsible for the accuracy of the references. Key the references (double-spaced) at the end of the manuscript. (If using End Note, set the style output to JAMA.) Cite references in text in order of appearance. Cite unpublished data, such as papers submitted but not yet accepted for publication, or personal communications, in parentheses in the text. If there are more than three authors, list only the first three authors and then use et al. Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names. Sample references are given below:
Journal article
1. Schambelan M, Benson CA, Carr A, et al. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. J Acquir Immune Defic Syndr. 2002;31:257?5.
Book chapter
2. Wortmann RL, Bentzel CJ. Renal handling of uric acid. In: Massry SG, Glassock RJ, eds. Massry and Glassock's Textbook of Nephrology. Philadelphia: Lippincott Williams & Wilkins, 2001;90?2.
Entire book
3. Mandell GL, Mildvan D, eds. Atlas of AIDS. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001.
Software
4. Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control and Prevention, 1994.
Online journals
5. Friedman SA: Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22?7. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990.
Database
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute, 1996. Updated March 29, 1996.
World Wide Web
7. Panel on Clinical Practices for the Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and Henry J. Kaiser Foundation, January 28, 2000. Available at: http://www.hivatis.org/guidelines/AA599.pdf.
Paper presented at a conference
8. Koenig L, Ellerbrock T, Pratt-Palmire M, et al. Prospective predictors of medication adherence: a study of the first six months of highly active antiretroviral therapy (HAART) using electronic monitoring [WePeB5818]. Presented at: XIV International AIDS Conference; 2002; Barcelona.
Figures: Cite figures consecutively in the text, and number them in the order in which they are discussed. We encourage authors to submit their figures through Editorial Manager, but if this is not possible, authors may send hard copies of the figures to the editorial office for scanning. On the hard copies, be sure to write the first author's last name, the figure number and figure part (1A, 1B, 1C), and an arrow to indicate the top edge of the figure on a label pasted to the back of each figure. Submit all artwork in camera-ready form; illustrations should be glossy prints or high-quality, laser-printed illustrations. Photocopies are unacceptable. Authors who submit manuscripts through Editorial Manager may submit figures as separate electronic files. High-quality hard copies may be requested once the manuscript has been accepted for publication. Lettering should be large enough that it will remain legible after figure reduction; typewritten or unprofessional lettering is unacceptable. Figure parts (A, B, C) may be left unlabeled (but clearly marked on back) for professional placement by the journal's printer.
Figure legends: Legends must be submitted for all figures. They should be included in the manuscript file, should be brief and specific, and should appear on a separate manuscript page after the references. Use scale markers in the image for electron micrographs, and indicate the type of stain used.
Color figures: The journal accepts for publication color figures that will enhance an article. Authors who submit color figures will receive an estimate of the cost for color reproduction. If they decide not to pay for color reproduction, they can request that the figures be converted to black and white at no charge.
Digital figures: Electronic art should be created/scanned and saved and submitted as either a TIFF (tagged image file format), an EPS (encapsulated postscript) file, or a PPT (Power Point) file. Line art must have a resolution of at least 1200 dpi (dots per inch), and electronic photographs—radiographs, CT scans, and so on—and scanned images must have a resolution of at least 300 dpi. If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files. Color images must be created/scanned and saved and submitted as CMYK files. All electronic art must be accompanied by high-resolution laser prints of the images. Files may be submitted electronically through the Editorial Manager interface, or on a 3?inch high-density disk, a CD-ROM, or an Iomega Zip disk. Please note that artwork generated from office suite programs such as Corel Draw and MS Word and artwork downloaded from the Internet (JPEG or GIFF files) cannot be used.
Tables: Create tables using the table creating and editing feature of your word processing software (eg, Word, WordPerfect). Do not use Excel or comparable spreadsheet programs. Group all tables at the end of the manuscript, or supply them together in a separate file. Cite tables consecutively in the text, and number them in that order. Key each on a separate sheet, and include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not embed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.
Style: Pattern manuscript style after the American Medical Association Manual of Style (9th edition). Stedman's Medical Dictionary (27th edition) and Merriam Webster's Collegiate Dictionary (10th edition) should be used as standard references. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate them. Use code numbers only when a generic name is not yet available. In that case, supply the chemical name and a figure giving the chemical structure of the drug. Capitalize the trade names of drugs and place them in parentheses after the generic names. To comply with trademark law, include the name and location (city and state in USA; city and country outside USA) of the manufacturer of any drug, supply, or equipment mentioned in the manuscript. Use the metric system to express units of measure and degrees Celsius to express temperatures, and use SI units rather than conventional units.
Genbank Accession Numbers: When manuscripts include or describe original nucleotide or amino acid sequence data, the sequence must be submitted to the GenBank or EMBL Data Library nucleotide sequence database and an accession number obtained from them. This accession number must be returned to the journal, where it will be placed after the Key Words on the title page in the printed article.
Instructions on how to submit data may be found in the printed submission information sheet made available by our editorial offices at the time of acceptance or by the staff at GenBank or EMBL (see addresses below). An accession number will be sent to you by GenBank within 7 days (48 hours, if received via electronic mail) once a submitted sequence has been received, processed, and the annotation accompanying it deemed complete and internally consistent with the sequence data. It is essential that the sequence data be submitted in computer-readable form.
Please note, acceptance of a manuscript by this journal assumes that the submitted data are to be made public upon receipt by the databank. Though there is every reason that data should be released immediately, many authors are concerned that submission of data before appearance of a manuscript may compromise their work. GenBank will, upon request, withhold release of the submitted data up to a specified date with a maximum of 6 months after submission.
You may contact the GenBank staff for further information, help, or submissions at: Electronic mail: genbank@genome.lanl.gov; Electronic mail, submissions only: gb-sub @genome.lanl.gov; U.S.A. telephone number: (505) 665-2177; Postal service: GenBank Submissions, Group T-10 Mail Stop K710, Los Alamos National Laboratory, Los Alamos, NM 87545, USA. You may contact EMBL Data Library for further information, help, or submissions at Electronic mail, data submission: datasubs@embl.bitnet; Telephone: 49(6221)387258; FAX: 49(6221)387306; Postal Service: EMBL Data Library Sybmissions, Postfach 10.2209, Meyerhofstrasse 1, 6900 Heidelberg, Germany.
Rapid Communications: Articles accepted as Rapid Communications will normally be published within 8 weeks of acceptance. When submitting a paper for consideration as a Rapid Communication, please adhere to the following guidelines:
- Submit your paper to Editorial Manager and designate the article type as "Rapid Communication." Please indicate to the Editor in either the notes or in an attached cover letter file why the paper merits special attention.
- If figures cannot be submitted to Editorial Manager, authors must send them by overnight express.
- The paper should not exceed 4 printed pages (approximately 12 double-spaced typewritten manuscript pages, including illustrations, tables, and references).
- The paper should include an abstract, key words, methods, results, discussion, and reference sections.
- The title page should include the corresponding author's telephone and fax numbers and e-mail address.
- Authors will receive proofs of their article for review by e-mail and will be expected to return corrections by fax within 24 hours of receipt. Changes received after this deadline will not be accepted.
Papers that are not accepted as Rapid Communications may be resubmitted as full-length articles.
Brief Reports: Brief Reports are short versions of clinical studies. They represent observations that are preliminary, speak for themselves, or offer new insight into a recognized condition. Submissions should not exceed 10 double-spaced manuscript pages, including references and table. Manuscripts that are too long for this category will be shortened at the editorial office or returned to the author for shortening.
Letters to the Editor: Letters to the Editor can provide additional comment on an article published in JAIDS, or can be a very concise report on study findings. Letters should be no more than 3 typeset pages (6 manuscript pages double-spaced, including references and either 1 figure or 1 table [but no abstract]).
Page proofs and corrections: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (eg, reprint order form) will be sent to the corresponding author via e-mail. Complete instructions will be provided with the e-mail for downloading and printing the files and for faxing the corrected pages to the publisher. Authors without an e-mail address will receive traditional paper page proofs. It is the author's responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style should be allowed to stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will not be allowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and corrections faxed within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.
Reprints: Authors will receive a reprint order form and a price list with the page proofs. Reprint requests should be faxed to the publisher with the corrected proofs, if possible. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department, Lippincott Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106 with any questions.
Publisher's contact: Fax corrected page proofs, reprint order forms, and any other related materials to 215-521-8483 or 215-521-8485.
Editorial Board
Publisher
Diana Pesek
DPesek@lww.com
Account Manager
January Bartle
jbartle@lww.com
Kevin Anderer
Marketing Manager
kanderer@lww.com
Business Offices
Lippincott Williams & Wilkins
530 Walnut Street
Philadelphia, PA 19016
Phone: 215-521-8300
http://www.lww.com
|
刊名字顺( Alphabetical List of Journals):
返回页首 